Celldex Therapeutics
CLDX
#4089
Rank
โ‚ฌ2.80 B
Marketcap
35,73ย โ‚ฌ
Share price
-0.22%
Change (1 day)
69.94%
Change (1 year)

Revenue for Celldex Therapeutics (CLDX)

Revenue in 2026 (TTM): โ‚ฌ0.73 Million

According to Celldex Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.74 Million. In 2025 the company made a revenue of โ‚ฌ1.31 Million a decrease over the revenue in the year 2024 that were of โ‚ฌ6.74 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Celldex Therapeutics from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ0.73 M-44.13%
2025 โ‚ฌ1.31 M-80.49%
2024 โ‚ฌ6.74 M8.35%
2023 โ‚ฌ6.22 M183.36%
2022 โ‚ฌ2.19 M-46.51%
2021 โ‚ฌ4.1 M-31.88%
2020 โ‚ฌ6.03 M89.06%
2019 โ‚ฌ3.18 M-61.74%
2018 โ‚ฌ8.33 M-21.51%
2017 โ‚ฌ10.62 M64.64%
2016 โ‚ฌ6.45 M28.68%
2015 โ‚ฌ5.01 M70.01%
2014 โ‚ฌ2.94 M-0.95%
2013 โ‚ฌ2.97 M-64.85%
2012 โ‚ฌ8.46 M18.7%
2011 โ‚ฌ7.13 M-79.72%
2010 โ‚ฌ35.17 M232.03%
2009 โ‚ฌ10.59 M98.68%
2008 โ‚ฌ5.33 M183.98%
2007 โ‚ฌ1.87 M-49.75%
2006 โ‚ฌ3.73 M43.34%
2005 โ‚ฌ2.6 M-48.44%
2004 โ‚ฌ5.05 M37.4%
2003 โ‚ฌ3.67 M-42.63%
2002 โ‚ฌ6.41 M69.29%
2001 โ‚ฌ3.78 M367.66%
2000 โ‚ฌ0.81 M-43.05%
1999 โ‚ฌ1.42 M-23.27%
1998 โ‚ฌ1.85 M69.23%
1997 โ‚ฌ1.09 M8.33%
1996 โ‚ฌ1.01 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
โ‚ฌ54.25 B 7,310,985.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ31.89 B 4,297,821.48%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ37.84 B 5,099,744.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
โ‚ฌ1.97 B 265,529.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚ฌ0.10 B 14,203.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.55 B 74,472.75%๐Ÿ‡บ๐Ÿ‡ธ USA